Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)

NAActive, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2017

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Blood sample

"Pre-treatment blood samples will be collected for downstream analyses:~* Three 6 ml EDTA samples for proteomic and genomic work package~* One 6 ml dry sample for auto-antibodies analysis in the immunology work package~* Two 4 ml EDTA samples for DNA extraction in the immunology work package~* Two 2.5 ml PAX Gene sample for RNA extraction in the immunology work package and the non-irradiated control in the genomic work package"

Trial Locations (1)

34298

Institut régional du Cancer de Montpellier, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER